MohanKumar, Krishnan
Namachivayam, Kopperuncholan
Song, Tanjing
Jake Cha, Byeong
Slate, Andrea
Hendrickson, Jeanne E. http://orcid.org/0000-0002-7928-3132
Pan, Hua
Wickline, Samuel A.
Oh, Joo-Yeun
Patel, Rakesh P.
He, Ling
Torres, Benjamin A.
Maheshwari, Akhil http://orcid.org/0000-0003-1502-7663
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL124078, HL133022, HL073646, HL124078, HL133022)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR067491)
American Heart Association (14GRNT20480307)
Article History
Received: 19 March 2018
Accepted: 27 June 2019
First Online: 2 August 2019
Competing interests
: S.A.W. has equity in Trasir Therapeutics Inc. The other authors declare no competing interests.